title: Clinical performance of a highly porous beta-TCP as the grafting material for maxillary sinus augmentation.
abstract: BACKGROUND
  Beta-tricalcium phosphate (β-TCP) is a synthetic bone substitute having high porosity and fast resorption. This retrospective study aimed at evaluating the effectiveness of an highly macroporous β-TCP for maxillary sinus floor augmentation.
  
  
  METHODS
  Twenty-seven consecutive patients (17 woman/10 men, mean age: 59.7 years) in 2 clinics underwent maxillary sinus augmentation by lateral approach using β-TCP as grafting material. Implant survival, prosthesis success, periimplant bone loss, oral hygiene level, soft tissue condition, complication occurrence, and patient satisfaction were assessed.
  
  
  RESULTS
  Thirty-one sinuses were successfully augmented. Sixty implants were placed. No sinus membrane perforations occurred. The mean follow-up after grafting was 39.3 ± 8.7 months (range, 22-52 months), and it was 30.5 ± 8.1 months (range, 15-43 months) after implant loading. No implants were lost. After 1 year of loading, marginal bone loss averaged -0.88 ± 0.46 mm (n = 54 implants). Mean full-mouth plaque and bleeding scores were 11.5% ± 4.8% and 3.5% ± 2.8%, respectively. No biological or mechanical complications were recorded. Patient satisfaction was very high.
  
  
  CONCLUSIONS
  Despite limited sample size and follow-up duration, highly macroporous β-TCP proved a valuable bone substitute for sinus augmentation, even when used alone.
authors.affiliation: *Adjunct Associate Professor, New York University College of Dentistry, Department of Implant Dentistry, New York, NY; Private Practice, Gretz-Armainvilliers, France. †President, French College of Implantology; Private Practice, Paris, France. ‡Academic Researcher, Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milano, Italy; Chief of the Section of Endodontics and Implant Surgery, Dental Clinic, IRCCS Istituto Ortopedico Galeazzi, Milano, Italy. §Academic Researcher, Director of the Research Center for Oral Health, Department of Biomedical, Surgical, and Dental Sciences, Università degli Studi di Milano, Milano, Italy; IRCCS Istituto Ortopedico Galeazzi, Milano, Italy.
authors.forename: Raphael
authors.initials: R
authors.lastname: Bettach
authors.forename: Bernard
authors.initials: B
authors.lastname: Guillaume
authors.forename: Silvio
authors.initials: S
authors.lastname: Taschieri
authors.forename: Massimo
authors.initials: M
authors.lastname: Del Fabbro
mesh_terms: D001672:Biocompatible Materials / Q000627:therapeutic use*; D018786:Bone Substitutes / Q000627:therapeutic use*; D002130:Calcium Phosphates / Q000627:therapeutic use*; D017268:Dental Prosthesis Retention; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D059546:Sinus Floor Augmentation / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D001672:Biocompatible Materials; D018786:Bone Substitutes; D002130:Calcium Phosphates; C485817:beta-tricalcium phosphate